148 related articles for article (PubMed ID: 27580960)
1. SOX10 expression in cutaneous scars: a potential diagnostic pitfall in the evaluation of melanoma re-excision specimens.
Jackett LA; McCarthy SW; Scolyer RA
Pathology; 2016 Oct; 48(6):626-8. PubMed ID: 27580960
[No Abstract] [Full Text] [Related]
2. Sox10-Positive Cells Within Scars: A Potential Diagnostic Pitfall.
Harvey NT; Acott NJ; Wood BA
Am J Dermatopathol; 2017 Oct; 39(10):791-793. PubMed ID: 27759704
[No Abstract] [Full Text] [Related]
3. Rapid SOX10 Immunostain on Fresh Frozen Tissue.
Donaldson MR; Deeths MJ; Weber LA
Dermatol Surg; 2016 Feb; 42(2):269-71. PubMed ID: 26808180
[No Abstract] [Full Text] [Related]
4. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
5. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
Lezcano C; Ho J; Seethala RR
Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
[TBL] [Abstract][Full Text] [Related]
6. SOX10 commonly stains scar in Mohs sections.
Donaldson MR; Weber LA
Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155034
[TBL] [Abstract][Full Text] [Related]
7. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma.
Robson A; Allen P; Hollowood K
Histopathology; 2001 Feb; 38(2):135-40. PubMed ID: 11207826
[TBL] [Abstract][Full Text] [Related]
8. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
[TBL] [Abstract][Full Text] [Related]
9. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
[TBL] [Abstract][Full Text] [Related]
10. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
[TBL] [Abstract][Full Text] [Related]
11. SOX-10 staining in dermal scars.
Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
[TBL] [Abstract][Full Text] [Related]
13. SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma.
Adkins BD; Geromes A; Zhang LY; Chernock R; Kimmelshue K; Lewis J; Ely K
Head Neck Pathol; 2020 Jun; 14(2):406-411. PubMed ID: 31222589
[TBL] [Abstract][Full Text] [Related]
14. Normal Expression of SRY-related HMG-BOX Gene 10 (SOX-10) in Recent and Old Cutaneous Scars is a Potential Mimicker of Desmoplastic Malignant Melanoma.
Febres-Aldana CA; Alexis J
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):197-204. PubMed ID: 30672775
[TBL] [Abstract][Full Text] [Related]
15. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
[TBL] [Abstract][Full Text] [Related]
16. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for Sox10 in Basaloid Neoplasms of The Skin.
Bush JW; Gru AA; Wick MR
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):114-118. PubMed ID: 30531326
[TBL] [Abstract][Full Text] [Related]
18. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
Chorny JA; Barr RJ
Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
[TBL] [Abstract][Full Text] [Related]
19. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
20. Refining diagnosis is the prerequisite for the correct treatment: The cytodiagnostic utility of SOX10 in the diagnosis of metastatic melanoma.
Kilitçi A; Elmas ÖF; Demirbaş A; Gamsızkan M; Atasoy M; Türsen Ü; Lotti T
Dermatol Ther; 2021 Jan; 34(1):e14657. PubMed ID: 33301211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
